The kick-off: Why we are looking forward to working with AEOLUS Europe
There are customer projects where you realise in the very first hour of the workshop: something fits together here. Values, clarity, ambition. AEOLUS Europe is just such a project.
At the beginning of the year, we signed the AEOLUS Europe the Brand Foundation Sprint started. A 5-day, structured process in which we worked with the team to develop positioning medical technology, brand identity, messaging and AI enablement. What struck us immediately was that this was not a company trying to ride a quick marketing wave. This was about something fundamental - about giving an industry a language that it doesn't yet have.
Among other things, AEOLUS develops veterinary intensive care units that treat animal intensive care with the same technological standards as human medicine. Touchscreen-controlled ICU units with precise oxygen, temperature and humidity control. UV disinfection between patients. Stress-reducing light therapy. NIR treatment for tissue regeneration. In short: critical care at a level that was simply not previously available in veterinary medicine.
We are delighted to be supporting this company with its positioning and market entry for Europe. And this article gives a first insight into what has been achieved so far - and why the task of building a brand in medical technology works differently than in other B2B sectors.
Why positioning in medical technology is a discipline in its own right
Before we dive into the sprint, a quick look at the market: medical technology is an industry in which engineering excellence is traditionally more important than brand clarity. The product is convincing, the sales pipeline is running, so why position it at all?
Three reasons why this is changing:
1. regulatory clarity is no longer sufficient for differentiation
Anyone who communicates in medical technology moves within regulatory corridors. Claims must be verifiable, promises of a cure are taboo, advertising follows strict standards. As a result, many medical technology brands sound very similar - functional, factual, interchangeable. In a market with growing competitive pressure, it is precisely this interchangeability that is becoming a problem.
2. buying centres are becoming more complex
A purchasing decision in a clinic today is rarely made by one person alone. Management, clinic management, medical staff, purchasing, IT - they all have different requirements, different languages, different pain points. A brand that only addresses one of these roles loses ground to one that engages the entire buying centre.
3 AI search changes how customers research
ChatGPT, Perplexity and Google AI Overviews are gradually replacing traditional search. Anyone appearing as a recommendation in an AI response needs a consistent story - not just good product data sheets. A brand that speaks the same language in every source will be recommended. One that communicates inconsistently will be dropped.
For AEOLUS Europe, there was a fourth point: The market itself is changing. Veterinary medicine is professionalising rapidly. What was pragmatic improvisation in many practices ten years ago is now becoming a clinical discipline. Animal intensive care units, once only found at a few university hospitals, are finding their way into larger veterinary clinics and specialised centres. The industry needs a language for this transition. And this is exactly where our work comes in.
Day 2 of the sprint: brand identity workshop
The Brand Foundation Sprint is divided into five days. Day 1 is the preflight - audit of existing materials, hypothesising, workshop preparation. Day 2 is the actual co-creation workshop on brand identity. This is exactly where we went a long way with AEOLUS Europe.
What exactly happens on such a day? Four steps that build on each other:
1. sharpen target groups: Who buys - and why?
The first exercise in the workshop is always the most honest: we force the team to name the actual decision-makers. Not generically („vets“), but segmented. Which clinic sizes? Which specialisations? Which investment cycles? What triggers lead someone to review an investment such as an ICU system - a new medical standard, a growth step, a generational change in hospital management?
At AEOLUS Europe, it became clear that the customer landscape is more heterogeneous than one might think at first glance. There are university hospitals with research requirements. There are large veterinary clinics with 24/7 emergency operations. There are specialised centres - oncology, cardiology, neonatology. Each of these groups has different drivers, different languages, different expectations of a manufacturer. A brand that treats everyone the same is not convincing to anyone.
2. determine differentiation: What can only you do?
One of the most difficult exercises for management is honest differentiation. Not „we are more innovative“, „we have higher quality“, „we are more customer-orientated“ - that's what everyone says. But rather: What specifically do you do that others don't?
At AEOLUS Europe, it quickly became clear that the differentiation lies not in individual features - but in the claim behind them. Namely: to treat intensive animal care with the same care, precision and dignity with which human medicine has developed its patient experience over the last 20 years. This is more than just a technical promise. It is an attitude towards animals as patients. And it is precisely this attitude that gave rise to the term that carries the brand today.
3. build value propositions: What will change for your customers?
Differentiation alone is not enough. It must be translated into a concrete benefit - otherwise it remains self-reflection. The question in this phase: What measurable changes occur in a clinic that works with AEOLUS? Better outcomes through more precise oxygen therapy. Reduced stress reactions thanks to sophisticated light control. Lower infection rates through UV disinfection. Faster recovery through NIR therapy. But also: a claim to the outside world with which the clinic can position itself - as an institution that makes no compromises in critical care for animals.
4. define brand principles: How do we speak, act and decide?
At the end of the day, there are principles. Not posters of values. But rather sentences that can be used in everyday life: When we have to make a decision, what guides us? How do we talk to customers, partners and our own team? What do we never do, even if it would be commercially attractive?
These principles are the foundation for everything that follows: brand story, messaging, AI enablement, visual identity. They are what later ensures that a brand sounds consistent - on the website, in the sales deck, in the LinkedIn post, in the congress speech.
Animal Experience: The concept that has emerged from the work
During the course of the day, something happened that sometimes occurs in such workshops - and is always the moment when you know that something viable is emerging: a concept emerges that nobody had previously been looking for.
In this case it was Animal Experience.
The term is obviously inspired by the „patient experience“ in human medicine - a concept that has long since extended the treatment of people beyond pure therapy. Daylight in the patient room, subdued acoustics in the emergency room, lighting control for calming, dignified communication. None of these are trivialities. They measurably improve outcomes - because less stress, more dignity and more control support healing.
This term does not yet exist in veterinary medicine. Animals in clinics are often still treated like diagnoses: medically correct, technically cared for, but with little systematic consideration of what they experience as patients. Stress due to noise. Insecurity due to unfamiliar lighting conditions. Cross-contamination due to insufficiently disinfected environments. Delayed recovery due to environments that are optimised for practicality, but not for the welfare of the animal.
AEOLUS Europe builds devices that do just that. An ICU with blue light therapy to reduce stress is not a marketing gimmick. It is the technical realisation of an approach that has become a matter of course in human medicine and is only just finding its way into veterinary medicine. And it is precisely this approach that needs a term to describe it. For a better understanding, here some information about ICU from the US website.
Animal Experience is this term. It is new. It has not yet been used in the industry. And it has the potential to become more than just a brand claim for a single company - namely a concept that reorganises an entire industry.
What medical technology companies can take away from this
Even though the sprint with AEOLUS Europe is not yet complete, three insights can already be derived from the first step that are relevant for other medical technology companies:
1. positioning in medical technology starts with attitude, not features
If you build brands in the healthcare sector solely on the basis of product specifications, you become interchangeable. Differentiation arises from the attitude towards patients, users and the market. This attitude must first be clear - then it translates into product, language and sales approach.
2. terms are strategic levers, not gimmicks
Anyone who occupies a term that is not yet used in the industry creates a position that can hardly be copied. „Animal Experience“ is not just a creative neologism - it is a semantic stake in a market that is only just beginning to find a language for itself.
3. brand work is particularly worthwhile when entering the market
Many medical technology companies wait until the product is established before positioning it. This is usually too late. Those who are clearly positioned from the outset save themselves time-consuming re-branding processes later on - and are more quickly recognised as a reference in the market. The the Brand Foundation Sprint This is precisely why it works: it gives companies the foundation in 5 days that would otherwise take six months.
What happens next
We are still at the beginning with AEOLUS Europe. Day 2 is dedicated to the brand story and messaging - in other words, the question of how the developed identity can be translated into sentences that work equally well in sales conversations, on the website and in congress communication. Day 4 is AI enablement: we build a prompt system that allows the AEOLUS team to consistently produce content that sounds like AEOLUS - not just any AI. Day 5 is co-creation: first finished assets that test the system in practice.
We are very much looking forward to travelling this path together with Klaus-Peter von der Eltz, David Song and the AEOLUS team. And we are looking forward to taking the industry with us - because what is being created here is not just a brand. It is a new term for an old promise: that animals in medicine deserve the same level of dignity and care as humans.
If you are in the medical technology sector yourself and are facing a similar task - positioning, market entry, new product launch feel free to contact us. The Brand Foundation Sprint is made for just such situations.
About AEOLUS Europe
AEOLUS has been developing veterinary equipment worldwide since 1996, specialising in intensive care. The product portfolio includes animal ICUs, oxygen cages, incubators for neonatal patients and supplementary hospital equipment. AEOLUS Europe is responsible for the market launch and expansion in Europe.
About Superblau
Superblau is a consultancy for positioning, go-to-market and digital products based in Cologne. We work with SMEs, scale-ups and ambitious brands in complex markets - including medical technology, science communication and the B2B industry. With the the Brand Foundation Sprint we bring brand strategy and AI enablement together in a 5-day format.
